Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-003766
Filing Date
2025-08-25
Accepted
2025-08-25 16:29:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13846
  Complete submission text file 0001172661-25-003766.txt   15892
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Subject) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-83932 | Film No.: 251251317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 CALIFORNIA STREET, SUITE 1210 SAN FRANCISCO CA 94108
Business Address 601 CALIFORNIA STREET, SUITE 1210 SAN FRANCISCO CA 94108 (415) 249-1280
Coastlands Capital LP (Filed by) CIK: 0002068530 (see all company filings)

EIN.: 333553930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G